Howland-Rose expects permitting at Avebury (near Zeehan) by November, and is targeting a decline development beginning January 2004.Hold on for the ride.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%